<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Westmead Institute for Medical Research in the news</title>
            <link>https://medicalxpress.com/</link>
            <language>en-us</language> 
            <description>provides the latest news from Westmead Institute for Medical Research</description>

                            <item>
                    <title>Predicting a rare but life-altering complication of common cancer treatment</title>
                    <description>A new study published in the Journal of Clinical Investigation has identified biomarkers that predict the likelihood of a patient developing checkpoint inhibitor-associated autoimmune diabetes before they are treated with immune checkpoint inhibitors. Australian researchers say identifying those at high risk of the condition would allow for earlier and closer monitoring and potentially reduce the number of people presenting with serious complications like diabetic ketoacidosis.</description>
                    <link>https://medicalxpress.com/news/2025-11-rare-life-complication-common-cancer.html</link>
                    <category></category>
                    <pubDate>Sat, 29 Nov 2025 09:20:01 EST</pubDate>
                    <guid isPermaLink="false">news683543913</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/predicting-a-rare-but.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
